Nucleic acid ligands capable of binding to internalin b or internalin a
AssigneesHitachi Chemical Company, Ltd., Hitachi Chemical Research Center, Inc.
InventorsCindy Yamamoto, Toshit Sen
Life of this patent
Estimating the term…
Loading patent…
AssigneesHitachi Chemical Company, Ltd., Hitachi Chemical Research Center, Inc.
InventorsCindy Yamamoto, Toshit Sen
Estimating the term…
The present disclosure relates to the isolation of a novel reagent selected for its binding characteristics to the proteins internalin B or internalin A. InIB is a surface-localized protein of Listeria monocytogenes that binds and activates the receptor tyrosine kinase Met. InIB promotes invasion of a number of cells including hepatocytes, endothelial and epithelial cell lines and causes activation of the actin-mediated internalization of the bacterium. InIA belongs to a large group of surface-localized leucine-rich repeat (LRR) proteins identified in the Listeria genome. InIA enables Listeria monocytogenes to invade non-phagocytic cells such as those of the human intestinal epithelium and is sufficient for adhesion to and inducing uptake into epithelial cells. The disclosed nucleic acid ligands to internalin B and internalin A may be useful for determining the presence or absence of internalin B, internalin A, or Listeria in food, clinical or environmental samples; they may also be useful as an agent for combating Listeria infection by binding to and inactivating the infection-promoting inlB or inlA proteins. One object is to incorporate these nucleic acid ligands into an in vitro diagnostic or biosensor platform designed to detect the presence or absence of internalin B, internalin A, or Listeria in food, clinical or environmental samples. Another object is to employ these nucleic acid ligands in methods for treating or preventing Listeria infection.
A method of assaying a sample for the presence of Listeria monocytogenes, comprising:
(canceled)
(canceled)
5-11. (canceled)
A method of treating Listeria monocytogenes infection in a mammal, comprising administering to the mammal an aptamer that specifically binds a protein selected from the group consisting of Listeria monocytogenes internalin B protein and Listeria monocytogenes internalin A protein at a concentration sufficient to reduce Listeria monocytogenes infection.
(canceled)
(canceled)
16-37. (canceled)
An aptamer comprising a nucleic acid molecule that comprises a sequence of SEQ ID NO:
A method of determining the amount of Listeria monocytogenes present in a sample using the biosensor of claim 4646, comprising:
Dependencies are inferred from the claim text.